Question

Is stem cell therapy for Heart Failure & Cardiac Repair covered by insurance?

Do not assume reimbursement for investigational heart-failure cell therapy. Coverage is policy-, country- and trial-specific. A legitimate sponsored trial may cover the investigational product and protocol-defined procedures, while routine cardiology care, devices, travel or treatment of complications may remain outside the sponsor budget. Obtain written confirmation before enrolment or payment.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for Heart Failure & Cardiac Repair

Private investigational heart-failure cell procedures can involve separate charges for catheterisation, imaging, laboratory testing, monitoring, travel and standard cardiology care. Prices do not indicate regulatory approval or expected benefit, and repeat dosing is not an established standard. Patients should request an itemised written quote and verify which costs are paid by the study sponsor, insurer and patient. Guideline-directed heart-failure treatment and transplant or device evaluation must not be delayed for an experimental procedure.

Am I a candidate? → · Heart Failure & Cardiac Repair: full overview → · Heart Failure & Cardiac Repair cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information